The response‐to‐retention hypothesis of atherogenesis reinforced
Abstract
Many lines of evidence indicate that the key initiating event in early atherosclerosis is the subendothelial retention of cholesterol-rich, atherogenic lipoproteins. Once retained, these lipoproteins provoke a cascade of responses that lead to disease in a previously non-lesional artery. We review recent experimental work that has substantially reinforced this hypothesis. Lipoprotein retention has been shown to be a pivotal requirement in the murine model of atherosclerosis: low-density lipoprotein, engineered through site-directed mutagenesis of apolipoprotein-B100 to bind poorly to arterial proteoglycans, causes relatively few lesions in vivo, even during significant hyperlipidemia. In addition, many molecules in the arterial wall that are involved in the retention of atherogenic lipoproteins and in arterial responses to retained material have recently been characterized. Overall, the response-to-retention hypothesis can now be regarded as a central paradigm in our understanding of the pathogenesis of this deadly disease.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Atherosclerosis is a low-grade chronic inflammatory disease of the arterial wall triggered by subendothelial retention of apolipoprotein B-containing lipoproteins.
“Atherosclerosis is a disease characterized by low-grade, chronic inflammation of the arterial wall and is triggered by the subendothelial retention of plasma-derived, apolipoprotein B (apoB)-containing lipoproteins in the affected inner layer of the arterial wall, the intima1–3.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [2]
The citation lists haven’t been fetched yet
References 36 · Cited by 395
- Authors
- Williams, K. J., & Tabas, I.
- Affiliations
- Thomas Jefferson University (US)
- Corresponding author
- Williams, Kevin Jon
- Venue
- Current Opinion in Lipidology
- Published
- 1998-10
- Volume
- 9
- Issue
- 5
- Pages
- 471-474
- ISSN
- 0957-9672 (ISSN-L)
- OpenAlex
- W2031899050
- Cited by
- 395
- References
- 36
- Citations by year
- 2026: 2 · 2025: 11 · 2024: 5 · 2023: 15 · 2022: 4 · 2021: 6 · 2020: 8 · 2019: 7 · 2018: 9 · 2017: 6 · 2016: 10 · 2015: 8 · 2014: 14 · 2013: 18 · 2012: 15
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Lipidology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Keywords
- atherogenesis, atherogenic lipoproteins, low-density lipoprotein, apolipoprotein B-100, proteoglycans, hyperlipidemia
- MeSH terms
- Animals, Apolipoproteins B, Arteriosclerosis, Humans, Lipoproteins, Models, Biological, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review